From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept.
作者信息
ElKayam O, Yaron M, Caspi D
出版信息
Ann Rheum Dis. 2000 Oct;59(10):839. doi: 10.1136/ard.59.10.839.
Abstract
摘要
相似文献
1
From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept.从轮椅到行走：重度慢性银屑病关节炎对依那西普的显著反应
Ann Rheum Dis. 2000 Oct;59(10):839. doi: 10.1136/ard.59.10.839.
2
Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.依那西普：关于其在类风湿关节炎、银屑病关节炎和幼年类风湿关节炎中应用的最新综述。
Drugs. 2002;62(17):2493-537. doi: 10.2165/00003495-200262170-00013.
3
Etanercept therapy of psoriatic arthritis in a patient with liver cirrhosis.一名肝硬化患者的银屑病关节炎的依那西普治疗。
Acta Derm Venereol. 2005;85(4):351-2. doi: 10.1080/00015550410026137.
4
5
Case definition of psoriatic arthritis.银屑病关节炎的病例定义。
Lancet. 2000 Dec 16;356(9247):2095; author reply 2096. doi: 10.1016/S0140-6736(00)03417-6.
6
[Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].[银屑病与银屑病性风湿病：依那西普对皮肤和关节病变的疗效]
Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):13-5. doi: 10.1016/S0151-9638(10)70012-0.
7
Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.依那西普治疗重度、难治性银屑病关节炎：两年后的持续疗效及使用模式变化
Clin Exp Rheumatol. 2002 Jan-Feb;20(1):115.
8
[Biological agents in treatment of psoriatic arthritis].[生物制剂在银屑病关节炎治疗中的应用]
Pol Merkur Lekarski. 2008 Jul;25(145):97-100.
9
Patient profiles in psoriatic disease: a case-based approach.银屑病性疾病患者概况：基于病例的方法。
Dermatol Nurs. 2007 Oct;Suppl:5-19; quiz 20-1.
10
Psoriatic arthritis: a guide for dermatology nurses.银屑病关节炎：皮肤科护士指南
Dermatol Nurs. 2003 Apr;15(2):107-10, 113-8; quiz 119.
引用本文的文献
1
Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.依那西普：关于其在类风湿关节炎、银屑病关节炎和幼年类风湿关节炎中应用的最新综述。
Drugs. 2002;62(17):2493-537. doi: 10.2165/00003495-200262170-00013.
Zotero 插件